What research recommendations have been made to evaluate the benefits and risks of cholesterol-lowering treatment in people with dialysis-dependent CKD?
Data from the AURORA, 4D and SHARP studies (dialysis cohort) should be pooled to undertake individual patient data meta-analysis to more comprehensively assess the benefits and risks of cholesterol-lowering treatment in people with dialysis-dependent CKD.